1. Home
  2. BOLT
  3. BOLT News

Latest Bolt Biotherapeutics Inc. (BOLT) News on October 19, 2025

BOLT

MT Newswires

16 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

BOLT

MT Newswires

17 days ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

BOLT

MT Newswires

17 days ago

Washington Shutdown Continues as US Equity Futures Trade Mixed Ahead of Opening Bell

BOLT

MT Newswires

17 days ago

Top Premarket Decliners

BOLT

MT Newswires

17 days ago

Bolt Biotherapeutics to Cut Workforce by 50%; Cancer Drug Trial Data Expected in Q3 of 2026

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
BOLT

GlobeNewswire

17 days ago

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates
BOLT

Zacks

5 months ago

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates

BOLT

Associated Press Finance

5 months ago

Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
BOLT

GlobeNewswire

5 months ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Biotech Alert: Searches spiking for these stocks today
BOLT

TipRanks

5 months ago

Biotech Alert: Searches spiking for these stocks today

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
BOLT

GlobeNewswire

5 months ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
BOLT

GlobeNewswire

6 months ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
BOLT

GlobeNewswire

6 months ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
BOLT

GlobeNewswire

7 months ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

BOLT

Associated Press Finance

7 months ago

Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
BOLT

GlobeNewswire

7 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics to Participate in Upcoming March Conferences
BOLT

GlobeNewswire

8 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
BOLT

GlobeNewswire

8 months ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations
BOLT

Simply Wall St.

a year ago

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates
BOLT

Zacks

a year ago

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates

BOLT

Associated Press Finance

a year ago

Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
BOLT

GlobeNewswire

a year ago

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation
BOLT

Simply Wall St.

a year ago

Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
BOLT

GlobeNewswire

a year ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics Announces Changes to its Board of Directors
BOLT

GlobeNewswire

a year ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics to Participate in Upcoming September Conferences
BOLT

GlobeNewswire

a year ago

Bolt Biotherapeutics to Participate in Upcoming September Conferences

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
BOLT

GlobeNewswire

a year ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

BOLT

GuruFocus.com

a year ago

Bolt Biotherapeutics Inc (BOLT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts ...

BOLT

MT Newswires

a year ago

Top Midday Decliners

Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate
BOLT

BioPharma Dive

a year ago

Bolt Biotherapeutics to lay off staff, abandon lead ADC candidate

Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
BOLT

GlobeNewswire

a year ago

Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
BOLT

Simply Wall St.

a year ago

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
BOLT

GlobeNewswire

2 years ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
BOLT

GlobeNewswire

2 years ago

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

BOLT

Associated Press Finance

2 years ago

Old Point Financial: Q4 Earnings Snapshot

Old Point Releases Fourth Quarter and Full Year 2023 Results
BOLT

PR Newswire

2 years ago

Old Point Releases Fourth Quarter and Full Year 2023 Results

35 Countries With The Best Education in the World
BOLT

Insider Monkey

2 years ago

35 Countries With The Best Education in the World

Chuck Royce Increases Stake in PowerFleet Inc
BOLT

GuruFocus.com

2 years ago

Chuck Royce Increases Stake in PowerFleet Inc

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024
BOLT

GlobeNewswire

2 years ago

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

Shareholders in Lake Shore Bancorp (NASDAQ:LSBK) are in the red if they invested five years ago
BOLT

Simply Wall St.

2 years ago

Shareholders in Lake Shore Bancorp (NASDAQ:LSBK) are in the red if they invested five years ago

BOLT

ACCESSWIRE

2 years ago

Zalatoris Acquisition Corp. Announces Confidential Submission of Draft Registration Statement to the SEC for Proposed Business Combination with AnyTech365

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
BOLT

ACCESSWIRE

2 years ago

INNO Holdings and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Syntec Optics (Nasdaq: OPTX) to Display Innovations at Photonics West 2024
BOLT

GlobeNewswire

2 years ago

Syntec Optics (Nasdaq: OPTX) to Display Innovations at Photonics West 2024

Sidoti Events, LLC's Virtual January Micro-Cap Conference
BOLT

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Specialty Retail Stocks Q3 Recap: Benchmarking Ulta (NASDAQ:ULTA)
BOLT

StockStory

2 years ago

Specialty Retail Stocks Q3 Recap: Benchmarking Ulta (NASDAQ:ULTA)

BOLT

Business Wire

2 years ago

AtlasClear Announces the Extension of Business Combination Agreement with Quantum FinTech Acquisition Corporation and the Restructuring of its Proposed Acquisition of Wilson-Davis & Co, Inc.

Virco Manufacturing Corporation (VIRC) Hit a 52 Week High, Can the Run Continue?
BOLT

Zacks

2 years ago

Virco Manufacturing Corporation (VIRC) Hit a 52 Week High, Can the Run Continue?

The Zacks Analyst Blog Highlights Murphy USA, Nine Energy Service and Sunoco
BOLT

Zacks

2 years ago

The Zacks Analyst Blog Highlights Murphy USA, Nine Energy Service and Sunoco

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign
BOLT

Investor's Business Daily

2 years ago

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign

Owning 47% shares,institutional owners seem interested in Zalatoris Acquisition Corp. (NYSE:TCOA),
BOLT

Simply Wall St.

2 years ago

Owning 47% shares,institutional owners seem interested in Zalatoris Acquisition Corp. (NYSE:TCOA),

Pacira Appoints Frank D. Lee as Chief Executive Officer
BOLT

GlobeNewswire

2 years ago

Pacira Appoints Frank D. Lee as Chief Executive Officer

High Tide Opens 160th Canna Cabana Location, the First on Tsuut'ina Nation
BOLT

PR Newswire

2 years ago

High Tide Opens 160th Canna Cabana Location, the First on Tsuut'ina Nation

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole
BOLT

InvestorPlace

2 years ago

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

Is Manitex International, Inc. (NASDAQ:MNTX) Potentially Undervalued?
BOLT

Simply Wall St.

2 years ago

Is Manitex International, Inc. (NASDAQ:MNTX) Potentially Undervalued?

12 Best Micro-Cap Dividend Stocks To Buy Now
BOLT

Insider Monkey

2 years ago

12 Best Micro-Cap Dividend Stocks To Buy Now

Can ContextLogic (NASDAQ:WISH) Afford To Invest In Growth?
BOLT

Simply Wall St.

2 years ago

Can ContextLogic (NASDAQ:WISH) Afford To Invest In Growth?

BOLT

Business Wire

2 years ago

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
BOLT

GlobeNewswire

2 years ago

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

NeuroStar TMS Receives Expanded Regulatory Approval in Japan
BOLT

GlobeNewswire

2 years ago

NeuroStar TMS Receives Expanded Regulatory Approval in Japan

3 Underperforming Bank Stocks You Better Not Be Buying
BOLT

InvestorPlace

2 years ago

3 Underperforming Bank Stocks You Better Not Be Buying

Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2023 Earnings Call Transcript
BOLT

Insider Monkey

2 years ago

Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2023 Earnings Call Transcript

BOLT

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Burning Rock Biotech Ltd Earnings Call

Burning Rock Reports Third Quarter 2023 Financial Results
BOLT

GlobeNewswire

2 years ago

Burning Rock Reports Third Quarter 2023 Financial Results

What Makes Immix Biopharma, Inc. (IMMX) a Good Fit for 'Trend Investing'
BOLT

Zacks

2 years ago

What Makes Immix Biopharma, Inc. (IMMX) a Good Fit for 'Trend Investing'

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?
BOLT

Simply Wall St.

2 years ago

Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Invest In Growth?

BOLT

Business Wire

2 years ago

BlackRock Closed-End Funds Announce Renewal of Share Repurchase Programs

BOLT

Business Wire

2 years ago

BlackRock Announces Distribution Increases for Municipal Closed-End Funds

BOLT

Zacks Small Cap Research

2 years ago

CBAT: Strong demand from battery storage customers leads to profitability.

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board
BOLT

Business Wire

2 years ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Announce Appointment of New Chairman of the Board

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights
BOLT

Business Wire

2 years ago

Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump
BOLT

Simply Wall St.

2 years ago

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance Completely
BOLT

Simply Wall St.

2 years ago

Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance Completely

CBAK Energy Technology, Inc. (NASDAQ:CBAT) Q3 2023 Earnings Call Transcript
BOLT

Insider Monkey

2 years ago

CBAK Energy Technology, Inc. (NASDAQ:CBAT) Q3 2023 Earnings Call Transcript

BOLT

Business Wire

2 years ago

BlackRock to Host Tax-Loss Harvesting & Closed-End Fund Opportunities Conference Call on November 13, 2023 at 11:00am ET

Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
BOLT

GlobeNewswire

2 years ago

Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

BOLT

Business Wire

2 years ago

AtlasClear and Wilson-Davis & Co. Announce New Client Relationship with Cathay Securities

Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
BOLT

GlobeNewswire

2 years ago

Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference

BOLT

Business Wire

2 years ago

Quantum FinTech Acquisition Corporation Stockholders Approve Business Combination with AtlasClear

Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors
BOLT

GlobeNewswire

2 years ago

Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors

Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023
BOLT

GlobeNewswire

2 years ago

Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023

Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for
BOLT

Zacks

2 years ago

Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for

BOLT

Associated Press Finance

2 years ago

First Guaranty Bancshares: Q3 Earnings Snapshot

First Guaranty Bancshares, Inc. Announces Third Quarter 2023 Results
BOLT

GlobeNewswire

2 years ago

First Guaranty Bancshares, Inc. Announces Third Quarter 2023 Results

Share on Social Networks: